ssNPA Device for Upper Airway Obstruction

Recruiting in Palo Alto (17 mi)

Overseen by Louise O'Brien, PhD

Age: < 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Michigan

Must not be taking: Anticoagulants

Disqualifiers: Severe autism, Airway collapse, others

No Placebo Group

Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the ssNPA treatment for upper airway obstruction?

Research shows that nasopharyngeal airways, like the ssNPA, are commonly used to help keep the airway open in patients with breathing issues, such as obstructive sleep apnea. In one study, patients with narrowing in the nasopharynx experienced significant improvement after treatment, suggesting that devices like the ssNPA could be effective in similar conditions. ^{1 2 3 4 5}

Is the ssNPA device generally safe for humans?

The nasopharyngeal airway, similar to the ssNPA device, is generally considered safe and is the least invasive method for managing upper airway obstruction. However, there are rare cases of complications, such as nasal trauma, especially after multiple insertion attempts. ^{4 6 7 8 9}

How is the ssNPA treatment different from other treatments for upper airway obstruction?

The Self-Supporting Nasopharyngeal Airway (ssNPA) is unique because it is a self-retaining device that can be used through the nasal or oral route to maintain an open airway without the need for invasive surgery. This makes it a less invasive option compared to surgical interventions, especially useful in conditions like the Pierre Robin sequence where temporary airway support is needed. ^{2 4 10 11 12}

Research Team

David Zopf, MD

Principal Investigator

The University of Wisconsin

Louise O'Brien, PhD

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for children with Hypotonic Upper Airway Obstruction and obstructive sleep apnea who've had a tonsillectomy or can't have one. They must show symptoms like snoring, daytime sleepiness, or hyperactivity. Kids with severe breathing issues during sleep, bleeding disorders, certain airway collapses, active COVID-19 infection, or those on blood thinners cannot join.

Inclusion Criteria

I experience symptoms like snoring, daytime sleepiness, or hyperactivity.

My child has severe sleep apnea or breathing issues at night confirmed by a sleep study.

I have had my tonsils removed or cannot have them removed due to health reasons.

Exclusion Criteria

I have a lung condition that restricts my breathing.

I have a medical condition that makes using a nasal airway support unsuitable.

You have a medical or social situation that could make it hard for you to follow the study plan or attend follow-up appointments. Some psychiatric conditions, like ADHD or conduct disorder, won't be excluded, but severe autism will be excluded.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Waitlist Control

Participants are placed on a waitlist for positive airway pressure (PAP) for 8 weeks

8 weeks

Treatment

Participants receive the Self-Supporting Nasopharyngeal Airway (ssNPA) device

8 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• Self-Supporting Nasopharyngeal Airway (ssNPA) (Other)

Trial Overview The study tests if the Self-Supporting Nasopharyngeal Airway (ssNPA) device helps treat obstructive sleep apnea in kids with muscle hypotonia affecting their upper airways. It's an alternative to traditional treatments post adenotonsillectomy.

Participant Groups

Group I: Self-Supporting Nasopharyngeal Airway (ssNPA) Experimental Treatment 1 Intervention

Group II: Standard of Care Active Control 1 Intervention

Waitlist control group: While waiting, participants will continue to receive the treatment they would have had before which will likely include being placed on the waiting list for positive airway pressure (PAP). After a period of being on the waitlist (8 weeks) there is an option to cross-over to the device arm.

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials

1,891

Recruited

6,458,000+

Marschall S. Runge

University of Michigan

Chief Executive Officer since 2015

MD, PhD

Karen McConnell

University of Michigan

Chief Medical Officer since 2020

MD

National Institutes of Health (NIH)

Collaborator

Trials

2,896

Recruited

8,053,000+

Dr. Jeanne Marrazzo

National Institutes of Health (NIH)

Chief Medical Officer

MD from University of California, Los Angeles

Dr. Jay Bhattacharya

National Institutes of Health (NIH)

Chief Executive Officer

MD, PhD from Stanford University

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials

3,987

Recruited

47,860,000+

Dr. Gary H. Gibbons

National Heart, Lung, and Blood Institute (NHLBI)

Chief Executive Officer since 2012

MD from Harvard Medical School

Dr. James P. Kiley

National Heart, Lung, and Blood Institute (NHLBI)

Chief Medical Officer since 2011

MD from University of California, San Francisco

Findings from Research

The new self-retaining nasopharyngeal airway was tested in 100 patients during anesthesia with spontaneous respiration, demonstrating its clinical effectiveness.

In addition to its intended nasal use, the airway can also function as a self-retaining oropharyngeal airway, expanding its versatility in clinical settings.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The cuffed pharyngeal airway. Feldman, SA., Fauvel, NJ., Ooi, R.[2007]

A case study highlighted that nasopharyngeal airways (NPAs) can be retained in patients for multiple days, leading to recurrent upper airway obstruction, which is a rare but serious complication.

Using larger-flanged NPAs may help prevent displacement into the nasal cavity, and the study emphasizes the importance of clear communication between emergency medical services and emergency department staff to ensure all inserted devices are accounted for.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

One Notable Complication of Nasopharyngeal Airway: A Case Report. Briggs, B., Countryman, C., McGinnis, HD.[2020]

In a study of 18 patients with obstructive sleep apnea (OSA) undergoing uvulopalatopharyngoplasty (UPPP), those with narrowing only in the nasopharynx (ENP group) showed an 86% improvement in respiratory disturbances after surgery, compared to only 18% in those with narrowing at other sites (NENP group).

The findings suggest that assessing the mechanics of the passive pharyngeal airway can help predict which patients are more likely to benefit from UPPP, highlighting the importance of identifying specific narrowing locations in the airway.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. Launois, SH., Feroah, TR., Campbell, WN., et al.[2013]

The study found that reduced upper airway dimensions during sleep are linked to lower sleep efficiency, highlighting the importance of airway size in sleep quality.

The nasopharyngeal appliance (NPA) was shown to be more effective than the mandibular repositioning splint (MRS) in improving outcomes for patients with upper airway resistance syndrome (UARS).

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Upper airway dimensions and sleep efficiency--three-dimensional imaging analysis and assessment of the nasopharyngeal appliance. Venkat, R., Vasanthakumar, M., Balakrishnan, D., et al.[2015]

The nasopharyngeal prong (NPP) is an effective, non-invasive solution for alleviating upper airway obstruction in children with craniofacial disorders, particularly in those with Robin sequence, where a small jaw and retrognathia can block the airway.

The NPP serves as a temporary measure that can help maintain airway patency while allowing for natural mandibular growth, potentially reducing the need for more invasive surgical interventions in selected cases.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

The role of the nasopharyngeal prong in craniofacial disorders in particular the Pierre Robin sequence. Abel, F., Wallis, C.[2022]

References

1. China pubmed.ncbi.nlm.nih.gov

[Postoperative application of nasopharyngeal airway in rhinogenous obstructive sleep apnea hypopnea syndrome patients]. [2014]

2. England pubmed.ncbi.nlm.nih.gov

The cuffed pharyngeal airway. [2007]

3. China (Republic : 1949- ) pubmed.ncbi.nlm.nih.gov

Nasopharyngeal tract length measurement in infants. [2015]

4. United States pubmed.ncbi.nlm.nih.gov

One Notable Complication of Nasopharyngeal Airway: A Case Report. [2020]

5. United States pubmed.ncbi.nlm.nih.gov

Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. [2013]

6. United States pubmed.ncbi.nlm.nih.gov

Aspiration of an oropharyngeal airway during nasotracheal intubation. [2022]

7. Poland pubmed.ncbi.nlm.nih.gov

Comparison of supraglottic airway laryngopharyngeal tube, oropharyngeal and nasopharyngeal airway use by Polish soldiers on the manikin with difficult airway. [2019]

8. United States pubmed.ncbi.nlm.nih.gov

Oropharyngeal foreign body after attempted nasal intubation: a case of traumatic middle turbinectomy. [2016]

9. England pubmed.ncbi.nlm.nih.gov

Securing a nasopharyngeal airway. [2022]

10. India pubmed.ncbi.nlm.nih.gov

Upper airway dimensions and sleep efficiency--three-dimensional imaging analysis and assessment of the nasopharyngeal appliance. [2015]

11. Netherlands pubmed.ncbi.nlm.nih.gov

The role of the nasopharyngeal prong in craniofacial disorders in particular the Pierre Robin sequence. [2022]

12. Australia pubmed.ncbi.nlm.nih.gov

Clinical experience in using a new type of nasal prong for administration of N-CPAP. [2019]